Follow
Nicholas P. Tobin
Nicholas P. Tobin
Karolinska Institutet and University Hospital
Verified email at ki.se - Homepage
Title
Cited by
Cited by
Year
Digital image analysis outperforms manual biomarker assessment in breast cancer
G Stålhammar, NF Martinez, M Lippert, NP Tobin, I Mølholm, L Kis, ...
Modern Pathology 29 (4), 318-329, 2016
1912016
CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment
SY Neo, Y Yang, J Record, R Ma, X Chen, Z Chen, NP Tobin, E Blake, ...
The Journal of clinical investigation 130 (3), 1185-1198, 2020
1592020
Cyclin D1, Id1 and EMT in breast cancer
NP Tobin, AH Sims, KL Lundgren, S Lehn, G Landberg
BMC cancer 11, 1-14, 2011
1292011
Use of molecular tools to identify patients with indolent breast cancers with ultralow risk over 2 decades
LJ Esserman, C Yau, CK Thompson, LJ van't Veer, AD Borowsky, ...
JAMA oncology 3 (11), 1503-1510, 2017
1202017
Impact of epithelial–stromal interactions on peritumoral fibroblasts in ductal carcinoma in situ
C Strell, J Paulsson, SB Jin, NP Tobin, A Mezheyeuski, P Roswall, ...
JNCI: Journal of the National Cancer Institute 111 (9), 983-995, 2019
1112019
Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival
NP Tobin, JC Harrell, J Lövrot, SE Brage, MF Stolt, L Carlsson, Z Einbeigi, ...
Annals of oncology 26 (1), 81-88, 2015
932015
Down-regulation of the oncogene cyclin D1 increases migratory capacity in breast cancer and is linked to unfavorable prognostic features
S Lehn, NP Tobin, P Berglund, K Nilsson, AH Sims, K Jirström, ...
The American journal of pathology 177 (6), 2886-2897, 2010
792010
Prognostic significance in breast cancer of a gene signature capturing stromal PDGF signaling
O Frings, M Augsten, NP Tobin, J Carlson, J Paulsson, C Pena, E Olsson, ...
The American journal of pathology 182 (6), 2037-2047, 2013
722013
STAT3 activity promotes programmed-death ligand 1 expression and suppresses immune responses in breast cancer
I Zerdes, M Wallerius, EG Sifakis, T Wallmann, S Betts, M Bartish, ...
Cancers 11 (10), 1479, 2019
712019
Role of tumor pericytes in the recruitment of myeloid-derived suppressor cells
JW Hong, NP Tobin, H Rundqvist, T Li, M Lavergne, Y García-Ibáñez, ...
Journal of the National Cancer Institute 107 (10), djv209, 2015
672015
The importance of molecular markers for diagnosis and selection of targeted treatments in patients with cancer
NP Tobin, T Foukakis, L De Petris, J Bergh
Journal of Internal Medicine 278 (6), 545-570, 2015
632015
The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours
A Lundberg, LS Lindström, J Li, JC Harrell, E Darai-Ramqvist, EG Sifakis, ...
Breast Cancer Research 21, 1-10, 2019
602019
Guidance molecule SEMA3A restricts tumor growth by differentially regulating the proliferation of tumor-associated macrophages
M Wallerius, T Wallmann, M Bartish, J Östling, A Mezheyeuski, NP Tobin, ...
Cancer research 76 (11), 3166-3178, 2016
572016
Astrocytes enhance glioblastoma growth
A Mega, M Hartmark Nilsen, LW Leiss, NP Tobin, H Miletic, L Sleire, ...
Glia 68 (2), 316-327, 2020
562020
Gene expression signatures and immunohistochemical subtypes add prognostic value to each other in breast cancer cohorts
A Lundberg, LS Lindström, JC Harrell, C Falato, JW Carlson, PK Wright, ...
Clinical Cancer Research 23 (24), 7512-7520, 2017
472017
High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer
J Paulsson, L Rydén, C Strell, O Frings, NP Tobin, T Fornander, J Bergh, ...
The Journal of Pathology: Clinical Research 3 (1), 38-43, 2017
472017
Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response
S Lehn, NP Tobin, AH Sims, O Stål, K Jirström, H Axelson, G Landberg
BMC cancer 14, 1-16, 2014
452014
Assessment of long-term distant recurrence-free survival associated with tamoxifen therapy in postmenopausal patients with luminal A or luminal B breast cancer
YY Nancy, A Iftimi, C Yau, NP Tobin, L van’t Veer, KA Hoadley, CC Benz, ...
JAMA oncology 5 (9), 1304-1309, 2019
432019
Immune gene expression and response to chemotherapy in advanced breast cancer
T Foukakis, J Lövrot, A Matikas, I Zerdes, J Lorent, N Tobin, C Suzuki, ...
British journal of cancer 118 (4), 480-488, 2018
432018
Separation of breast cancer and organ microenvironment transcriptomes in metastases
MA Alzubi, TH Turner, AL Olex, SS Sohal, NP Tobin, SG Recio, J Bergh, ...
Breast Cancer Research 21, 1-15, 2019
422019
The system can't perform the operation now. Try again later.
Articles 1–20